Composition
- Active ingredients
- INSULIN GLULISINE RECOMBINANT 300 UNITS/3ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA021629.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Apidra Solostar
- Active substance
- insulin glulisine recombinant
- Route
- Subcutaneous
- Dosage form
- Injectable
- Applicant
- Sanofi Aventis US
- Status
- Prescription
- FDA approval
- 16 Apr 2004
- Application
- BLA021629-003